v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash Flows Used in Operating Activities    
Net loss $ (34,998) $ (12,872)
Adjustment to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 56 32
Amortization of intangible assets 230 91
Amortization of right-of-use asset 223 53
Non-cash interest (income) expense, net (82) 145
Stock-based compensation 4,847 455
Impairment of intangible assets 531
Loss on extinguishment of debt 421
Warrant issuance expense 2,016
Change in fair value of warrant liability 21,447 (503)
Loss on disposal of the Inpixon Business 831
Other income (250)
Other (2) 3
Changes in operating assets and liabilities:    
Accounts receivable and other receivables 4,335 157
Inventories (3,994) (19)
Prepaid expenses and other current assets (2,729) (594)
Other assets 12 348
Accounts payable (1,854) (624)
Related party payables (51)
Accrued expenses and other current liabilities 2,136 (4,892)
Accrued interest (49) 67
Deferred revenue (416) 46
Operating lease obligation (197) (52)
Net Cash Used in Operating Activities (10,454) (15,242)
Cash Flows Used in Investing Activities    
Purchase of property and equipment (131) (45)
Net cash paid on disposal of the Inpixon Business (694)
Net Cash Used in Investing Activities (825) (45)
Cash Provided by Financing Activities    
Net proceeds from the exercise of liability classified warrants 7,439 1
Net proceeds from sale of common stock and pre-funded warrants via public offerings 21,651
Net proceeds from ATM stock offering 1,667
Redemption of Series 9 preferred stock (1,427)
Net borrowings on line-of-credit 4,638
Payment of debt issuance costs (565)
Repayments of promissory notes (2,000) (2,719)
Net Cash Provided by Financing Activities 9,512 19,173
Effect of Foreign Exchange Rate on Changes on Cash 33 17
Net (Decrease) Increase in Cash and Cash Equivalents (1,734) 3,903
Cash and Cash Equivalents - Beginning of period 16,919 4,105
Cash and Cash Equivalents - End of period 15,185 8,008
Supplemental Disclosure of cash flow information:    
Interest 263 281
Income Taxes
Non-cash investing and financing activities    
Common shares issued for conversion of debt and accrued interest 750
Warrant liabilities exchanged for common stock 3,299
Conversion of Series 10 Preferred Stock to pre-funded warrants $ 24,186

Source

10-Q PDF
XBRL